Self-collected swabs for HPV screening
Self-Collected Swabs for Primary Primary Human Papilloma Virus (HPV) Screening
University of Hawaii · NCT05989464
This study is testing if letting women collect their own samples for HPV testing can help more women in Hawaii get screened for cervical cancer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 84 (estimated) |
| Ages | 25 Years and up |
| Sex | Female |
| Sponsor | University of Hawaii (other) |
| Locations | 1 site (Honolulu, Hawaii) |
| Trial ID | NCT05989464 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a self-swab protocol for primary Human Papilloma Virus (HPV) testing to increase cervical cancer screening rates among unscreened women in Hawaii. The research aims to address barriers to screening by allowing women to collect their own samples, thereby improving accessibility and comfort. The findings may support the adoption of self-swab protocols at Kalihi Palama Health Center and other Federally Qualified Health Centers in Hawaii, potentially leading to higher screening rates and earlier detection of cervical cancer.
Who should consider this trial
Good fit: Ideal candidates are women aged 25 years or older who have a cervix and have not been adequately screened for cervical cancer.
Not a fit: Patients with a known history of cervical cancer or those currently pregnant may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly increase cervical cancer screening rates among underserved populations, leading to earlier detection and better outcomes.
How similar studies have performed: Previous studies have shown success with self-collected swabs for HPV testing in various populations with low screening rates, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age of 25 years or older * Have a cervix * Have an indication for cervical cancer screening per Accreditation Council for Continuing Medical Education (ASCCP) guidelines * Have been previously referred to women's health in the past 5 years or subjects have declined a women's health referral. * Subjects must not have been seen in women's health clinic since referral was placed Exclusion Criteria: * Subjects unable to consent in one of the following languages: English, Chuukese, or Marshallese * Subjects with known history of cervical cancer * Subjects that are currently pregnant or within 3 months of giving birth
Where this trial is running
Honolulu, Hawaii
- Kalihi Palama — Honolulu, Hawaii, United States (RECRUITING)
Study contacts
- Principal investigator: Ann Chang, MD — University of Hawaii
- Study coordinator: Jonathan Riel
- Email: jriel@hawaii.edu
- Phone: (808) 203-6502
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: HPV, hpv, self swab, cervical cancer